Beam Therapeutics, Inc. (BEAM)
20.92
-0.02
(-0.10%)
USD |
NASDAQ |
Nov 20, 16:00
21.03
+0.11
(+0.53%)
After-Hours: 19:36
Beam Therapeutics Gross Profit (TTM) : 124.52M for Sept. 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 124.52M |
| June 30, 2026 | 133.79M |
| March 31, 2026 | 141.64M |
| December 31, 2025 | 117.45M |
| September 30, 2025 | 33.63M |
| June 30, 2025 | 38.29M |
| March 31, 2025 | 41.56M |
| December 31, 2024 | 41.59M |
| September 30, 2024 | 327.80M |
| June 30, 2024 | 328.72M |
| March 31, 2024 | 335.35M |
| December 31, 2023 | 350.58M |
| September 30, 2023 | 53.60M |
| June 30, 2023 | 54.06M |
| March 31, 2023 | 52.38M |
| December 31, 2022 | 38.34M |
| September 30, 2022 | 70.54M |
| Date | Value |
|---|---|
| June 30, 2022 | 60.36M |
| March 31, 2022 | 49.22M |
| December 31, 2021 | 46.05M |
| September 30, 2021 | -2.938M |
| June 30, 2021 | -2.938M |
| March 31, 2021 | -2.938M |
| December 31, 2020 | -2.938M |
| September 30, 2020 | -1.881M |
| June 30, 2020 | -1.881M |
| March 31, 2020 | -1.881M |
| December 31, 2019 | -2.822M |
| September 30, 2019 | -1.474M |
| June 30, 2019 | -1.538M |
| March 31, 2019 | -1.538M |
| December 31, 2018 | -0.597M |
| September 30, 2018 | -0.064M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Intellia Therapeutics, Inc. | 40.65M |
| Twist Bioscience Corp. | 240.80M |
| Prime Medicine, Inc. | -0.215M |
| Sarepta Therapeutics, Inc. | 1.074B |
| Q32 Bio, Inc. | 53.39M |